BPC-157 is reported to act locally, supporting angiogenesis and stabilising the repair environment at a defined site
Overall, AOD-9604 appears to influence body fat metabolism more than the digestive system itself
Its important to weigh the benefits and side effects of using BPC-157
Cellular methylation and NAD pool dynamics the only well-characterized chemical probe that simultaneously raises tissue NAD and SAM, enabling clean studies of the methyl-donor / NAD-salvage interface [1,2]
Advanced / Aggressive Protocol (2 mL = ~10.0 mg/mL) Note: The 12 mg dose represents the highest dose tested in Phase 2 trials [3] [4] , producing maximum weight-loss efficacy (~24% body weight at 48 weeks)
Ongoing monitoring, follow-up lab testing, and protocol adjustments are built into the program to optimize outcomes and maintain clinical precision